Phoenix, Arizona, United States Atlas Capital LLC appeared to be the VC, which was created in 2012. The main department of described VC is located in the Phoenix. The venture was found in North America in United States.
Considering the real fund results, this VC is 0 percentage points less often commits exit comparing to other organizations. Comparing to the other companies, this Atlas Capital LLC performs on 9 percentage points less the average number of lead investments. The fund is generally included in less than 2 deals every year. The high activity for fund was in 2018. Deals in the range of 50 - 100 millions dollars are the general things for fund.
Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - China. The fund has exact preference in some founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Haihe Biopharma, Cheng Guang, NewBanker. Among the most popular fund investment industries, there are Biotechnology, Media and Entertainment.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Atlas Capital LLC, startups are often financed by Trustbridge Partners, Redpoint Ventures China, Marc Bell Ventures. The meaningful sponsors for the fund in investment in the same round are Yingke Capital, ShengJing360, Qiming Venture Partners. In the next rounds fund is usually obtained by Qiming Venture Partners, Matrix Partners China, Great Chiliocosm Capital.
Related Funds
| Fund Name | Location |
| Access2net | France, Ile-de-France, Paris |
| Asan Sharing Foundation | Seoul, Seoul-t'ukpyolsi, South Korea |
| Biocartis | Lausanne, Switzerland, Vaud |
| Colonial Pipeline | Alpharetta, Georgia, United States |
| Dongfang Jixing Xinxi | Beijing, Beijing, China |
| Forever Young Capital | - |
| Fujimi Corporation | Oregon, Tualatin, United States |
| Global Philanthropic | - |
| Great Eagle Holdings Limited | China, Hong Kong, Hong Kong Island |
| Internet.com Venture Partners | New York, New York, United States |
| JCBank | China, Jincheng, Shanxi |
| Morningside Venture Capital | China, Shanghai, Xuhui |
| Philips Health Technology Ventures | - |
| Sage Group | Newcastle upon Tyne, North East, United Kingdom |
| Shrieve Chemical | Texas, The Woodlands, United States |
| SK Group | Seoul, Seoul-t'ukpyolsi, South Korea |
| Takwin | Hefa, Hefa, Israel |
| University of Bristol Enterprise Fund | England, London, United Kingdom |
| Xinrui Zheshang Touzi | China, Hangzhou, Zhejiang |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Haihe Biopharma | $146M | 11 Feb 2019 | Shanghai | ||
| 09 May 2018 | Dongcheng District, Beijing, China | ||||
| $14M | 13 Mar 2018 | Dongcheng District, Beijing, China | |||
NewBanker | 06 Dec 2017 | Dongcheng District, Beijing, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Haihe Biopharma | $146M | 11 Feb 2019 | Shanghai | ||
| 09 May 2018 | Dongcheng District, Beijing, China | ||||
| $14M | 13 Mar 2018 | Dongcheng District, Beijing, China | |||
NewBanker | 06 Dec 2017 | Dongcheng District, Beijing, China |
